
Elevated Lactate vs Lactic Acidosis: Words That Change Care And Outcomes
Jun 16, 2026 - 9:24
Radio and PodcastLive Radio & Podcasts
The double-blind, randomized phase III EMPEROR-Preserved trial showed a benefit of the sodium-glucose cotransporter-2 (SGLT2) inhibitor empagliflozin in patients with heart failure with preserved ejection fraction (HFpEF...